  Background: The development of classification methods for personalized
medicine is highly dependent on the identification of predictive genetic
markers. In survival analysis it is often necessary to discriminate between
influential and non-influential markers. Usually, the first step is to perform
a univariate screening step that ranks the markers according to their
associations with the outcome. It is common to perform screening using Cox
scores, which quantify the associations between survival and each of the
markers individually. Since Cox scores do not account for dependencies between
the markers, their use is suboptimal in the presence highly correlated markers.
Methods: As an alternative to the Cox score, we propose the
correlation-adjusted regression survival (CARS) score for right-censored
survival outcomes. By removing the correlations between the markers, the CARS
score quantifies the associations between the outcome and the set of
"de-correlated" marker values. Estimation of the scores is based on inverse
probability weighting, which is applied to log-transformed event times. For
high-dimensional data, estimation is based on shrinkage techniques. Results:
The consistency of the CARS score is proven under mild regularity conditions.
In simulations, survival models based on CARS score rankings achieved higher
areas under the precision-recall curve than competing methods. Two example
applications on prostate and breast cancer confirmed these results. CARS scores
are implemented in the R package carSurv. Conclusions: In research applications
involving high-dimensional genetic data, the use of CARS scores for marker
selection is a favorable alternative to Cox scores even when correlations
between covariates are low. Having a straightforward interpretation and low
computational requirements, CARS scores are an easy-to-use screening tool in
personalized medicine research.
